Human Vaccines & Immunotherapeutics

Visão geral
Metrics
Identidade
Informação adicional documento
Ver todos

Qualis

A3

código do país

US

tipo

journal

publicação venue de

How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?. 19:2164144. 2023-01-01
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults. 19:1-12. 2023-01-01
Pandemic?s influence on parents? attitudes and behaviors toward meningococcal vaccination. 19:2179840. 2023-01-01
Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination. 19:1-14. 2023-01-01
Evaluating the quality of HPV vaccine-related information on the Portuguese Internet. 18:1-6. 2022-01-01
Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception. 18:1-7. 2022-01-01
Unveiling the contributions of immunization for progressing towards Universal Health Coverage. 18:e2036048-1-e2036048-8. 2022-01-01
Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines? immunogenicity. 1:1-12. 2022-01-01
Correction. 17:927-927. 2021-01-01
Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019. 1:1-10. 2021-01-01
Development of synthetic antigen vaccines for COVID-19. -:1-16. 2021-01-01
Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines. 17:1-4. 2021-01-01
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults. 17:01-09. 2021-01-01
Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020. -:1-17. 2021-01-01
Nosocomial acute gastroenteritis outbreak caused by an equine-like G3P[8] DS-1-like rotavirus and GII.4 Sydney[P16] norovirus at a pediatric hospital in Rio de Janeiro, Brazil, 2019. 1:1-7. 2021-01-01
The hindrances to perform the COVID-19 vaccination in Brazil. 17:3989-4004. 2021-01-01
Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains. 17:1-1. 2021-01-01
Vaccines and routine immunization strategies during the COVID-19 pandemic. 17:400-407. 2021-01-01
A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions. 1:1-1950. 2020-01-01
Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks. 1:1-19. 2020-01-01
Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. 23:1-11. 2020-01-01
DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model. 1:1-7. 2020-01-01
Effect of pneumococcal conjugate vaccines on mortality from lower respiratory infections and pneumonia among under-fives. 1:1-545. 2020-01-01
Emerging CAR T cell therapies: clinical landscape and patent technological routes. 16:1424-1433. 2020-01-01
Epidemiology of pertussis among adolescents, adults, and older adults in selected countries of Latin American: a systematic review. 17:1-14. 2020-01-01
Facebook HPV vaccine campaign: insights from Brazil. 15:1-11. 2020-01-01
Human papillomavirus prevalence, genomic diversity and related risk factors in HIV-positive women from a countryside city in the state of Rio de Janeiro. 1:1-7. 2020-01-01
Impact of funding influenza vaccination on coverage among Australian children: a national study using MedicineInsight, a large general practice database. 16:630-635. 2020-01-01
Methods for predicting vaccine immunogenicity and reactogenicity. 16:269-276. 2020-01-01
Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. 16:965-971. 2020-01-01
Portrait of an ISV fellow Clarisa Beatriz Palatnik de Sousa. 1:1. 2020-01-01
Zika virus-an update on the current efforts for vaccine development. 1:1-5. 2020-01-01

tem uma área de assunto

publisher

Taylor & Francis

is open access

False invalid format

is in DOAJ

False invalid format